Navigation Links
Cross-country collaboration leads to new leukemia model
Date:7/31/2013

Eight years ago, two former Stanford University postdoctoral fellows, one of them still in California and the other at the Harvard Stem Cell Institute (HSCI) in Cambridge, began exchanging theories about why patients with leukemia stop producing healthy blood cells. What was it, they asked, that caused bone marrow to stop producing normal blood-producing cells?

And after almost a decade of bicoastal collaboration, Emmanuelle Passegu, now a professor in the Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research at the University of California, San Francisco, and Amy Wagers, a professor in Harvard's Department of Stem Cell and Regenerative Biology, have the answer.

They have found that cancer stem cells actively remodel the environment of the bone marrow, where blood cells are formed, so that it is hospitable only to diseased cells. This finding could influence the effectiveness of bone marrow transplants, currently the only cure for late-stage leukemia, but with a 25 percent success rate due to repopulation of residual cancer cells.

Their results, which were recently published online in Cell Stem Cell, show that leukemia cells cannot replicate in the bone marrow niche as well as healthy blood-forming stem cells can, so the cancer cells gain the advantage by triggering bone marrow-maintenance cells to deposit collagen and inflammatory proteins, leading to fibrosis or scarring of the bone marrow cavity.

"They remodel the microenvironment so that it is basically callous, kicking the normal stem cells out of the bone marrow and encouraging the production of even more leukemic cells," Passegu said. This model is a shift from the widely held theory that cancer cells simply crowd out the healthy cells.

Passegu and Wagers stayed in touch, despite the distance between their laboratories, via annual, two-day, "off-the-record" symposiums of junior investigators at the Harvard Stem Cell Institute and
'/>"/>

Contact: B. D. Colen
bd_colen@harvard.edu
617-495-7821
Harvard University
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. La Jolla Institute continues longtime collaboration with Kyowa Hakko Kirin California
2. Ben-Gurion U. and UChicago research collaboration targets water resource innovations
3. NIH to fund collaborations with industry to identify new uses for existing compounds
4. First international collaboration to showcase latest body of evidence of dairy health benefits
5. Missouri Botanical Garden program announces collaboration with LHerboretum
6. Missouri Botanical Garden program annouces collaboration with LHerboretum
7. Collaboration to establish new computational resources for metabolomics
8. Oregon Biodiversity Information Center wins 2013 Natureserve Network Collaboration Award
9. Nottingham-Australia collaboration on environmental conservation of the future
10. Harvards Wyss Institute and Sony DADC announce collaboration on Organs-on-Chips
11. Scripps Research and Takeda Pharmaceuticals announce expanded research collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/11/2015)... 11, 2015  Synaptics Incorporated (NASDAQ: SYNA ... today announced the appointment of Wajid Ali ... Officer, reporting to Rick Bergman , President ... Financial Officer, Kathleen Bayless , who announced ... Mr. Ali brings extensive financial management expertise to ...
(Date:5/10/2015)... , May 11, 2015 Fingerprint ... sensors FPC1025 and FPC1155 from the distributor World Peace Industrial ... FPC,s distributors in Asia . Deliveries are ... will be used by smartphone manufacturers in China ... in the communicated revenue guidance of + 1 000 MSEK for ...
(Date:5/6/2015)... 2015 LifeBEAM, a developer of bio-sensing technology, ... today that they will expand their partnership in bio-sensing ... cycling helmet and the first joint project between the ... in order to give cyclists more style choices and ... and Lazer announced their plan to release a new ...
Breaking Biology News(10 mins):Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 235 Million 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3
... Diego State University and the University of California have been ... on an unusual whale species and have discovered a new ... in Finite Element Modeling (FEM), Computed tomography (CT) scanning, and ... and anatomy of a Cuviers beaked whale when a sonar ...
... Your mother always told you to do your geometry ... like Parkinsons and Alzheimers, this advice turns out to ... landscape of proteins, shape determines the all-important function of ... molecule responsible for Parkinsons binds with the cell membrane, ...
... As organic farming becomes more common, methods to ... In a recent study in Journal of Environmental ... determine if non-organic, synthetic fertilizers were used on ... Murciano de Investigacin y Desarrollo Agrario y Agrario ...
Cached Biology News:How is that whale listening? 2It's all about geometry: Protein contact surfaces hold key to cures 2It's all about geometry: Protein contact surfaces hold key to cures 3Is it organic or not? 2
(Date:6/2/2015)... LA (PRWEB) June 02, 2015 ... gene synthesis to improve protein expression, announced the formation ... includes six executives and entrepreneurs with a broad range ... industries. , The team includes: , Jimmy Roussel, ... , Roussel has a background in technology and marketing. ...
(Date:6/1/2015)... June 1, 2015 ... announced the addition of the "Oxidative ... Services), Test Type (Indirect, Enzyme-based, Reactive Oxygen ... End Users - Global Forecast to 2020" ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , The ...
(Date:6/1/2015)... , June 1, 2015 ... Decipher® genomic analysis platform, successfully classified various ... genomic expression of certain biomarkers, including one ... Importantly, this unique genomic signature has potential ... to neoadjuvant chemotherapy in patients with muscle-invasive ...
(Date:6/1/2015)... N.J. , June 1, 2015  Novartis ... clinical study of CTL019, an investigational chimeric antigen ... potential in the treatment of specific types of ... conducted by the University of Pennsylvania,s Perelman School ... refractory (r/r) diffuse large B-cell lymphoma (DLBCL) and ...
Breaking Biology Technology:GenoCAD Announces New Board of Advisors, Improves Protein Expression Using Custom Gene Synthesis 2GenoCAD Announces New Board of Advisors, Improves Protein Expression Using Custom Gene Synthesis 3Oxidative Stress Assay Market 2015 - Global Forecast to 2020 2GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting 2GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting 3GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting 4Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 2Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 3Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 4Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 5Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 6
... 8 AGA Medical today issued the,following response to ... purported victory Occlutech GmbH had achieved in the AIPPI ... a,proceeding of some sort was conducted before the AIPPI ... is false,and misleading. AGA has not been involved in ...
... Exelixis,Inc. (Nasdaq: EXEL ) will release its ... February 14, 2008 after the markets close.,The announcement will ... ET/ 2:00,p.m. PT, in which Exelixis management will discuss ... may be accessed in the Event,Calendar page under Investors ...
... today announced that its first quarter fiscal year 2008 financial,results will ... financial results, Biodel,s senior management team will,host a conference call to ... February 14, 2008 Schedule:, 8:00 a.m. ... will be distributed by PR Newswire, 8:20 a.m. ...
Cached Biology Technology:AGA Medical Corporation Responds to Occlutech Statement on the Status of the Ongoing Patent Litigation in Europe 2Biodel Inc. to Announce First Quarter Fiscal Year 2008 Financial Results on February 14, 2008 2Biodel Inc. to Announce First Quarter Fiscal Year 2008 Financial Results on February 14, 2008 3
Mouse monoclonal [15-2] to Mannose Receptor (Biotin) ( Abpromise for all tested applications). entrezGeneID: 4360 SwissProtID: P22897...
... Immunogen: Peptide corresponding ... human, mouse, and rat phospho-FAK (Ser843) ... NM_153831 Quality ... Molecular Weight: ...
SAPK/JNK Antibody...
Mouse monoclonal [DJR3] to DcR1 (Biotin) ( Abpromise for all tested applications). entrezGeneID: 8794 SwissProtID: O14798...
Biology Products: